Privia Health Group (PRVA) News Today → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free PRVA Stock Alerts $17.37 +0.11 (+0.64%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 9:23 AM | insidertrades.comInsider Buying: Privia Health Group, Inc. (NASDAQ:PRVA) Director Buys 5,306 Shares of StockJune 1 at 8:12 AM | americanbankingnews.comPrivia Health Group (NASDAQ:PRVA) Upgraded to "Strong-Buy" by Baird R WJune 1 at 7:29 AM | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Upgraded to Strong-Buy at Baird R WBaird R W upgraded shares of Privia Health Group to a "strong-buy" rating in a research note on Thursday.May 31 at 4:58 PM | marketbeat.comInsider Buying: Privia Health Group, Inc. (NASDAQ:PRVA) Director Acquires 5,306 Shares of StockPrivia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) Director Adam Boehler purchased 5,306 shares of the company's stock in a transaction dated Wednesday, May 29th. The stock was bought at an average cost of $16.50 per share, for a total transaction of $87,549.00. Following the completion of the transaction, the director now owns 5,773,158 shares in the company, valued at $95,257,107. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website.May 31 at 6:02 AM | americanbankingnews.comPrivia Health Group (NASDAQ:PRVA) Coverage Initiated by Analysts at Robert W. BairdMay 30 at 12:53 PM | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Shares Up 4.1%Privia Health Group (NASDAQ:PRVA) Trading Up 4.1%May 30 at 9:26 AM | globenewswire.comPrivia Health to Participate in the William Blair Growth Stock ConferenceMay 30 at 8:22 AM | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Receives New Coverage from Analysts at Robert W. BairdRobert W. Baird initiated coverage on Privia Health Group in a research note on Thursday. They set an "outperform" rating and a $23.00 price target on the stock.May 30 at 5:16 AM | marketbeat.comJanney Montgomery Scott LLC Takes Position in Privia Health Group, Inc. (NASDAQ:PRVA)Janney Montgomery Scott LLC acquired a new stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 51,020 shares of the company's stoMay 28, 2024 | americanbankingnews.comPrivia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMay 28, 2024 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) have been given an average rating of "Moderate Buy" by the twelve brokerages that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and ten have assignMay 26, 2024 | 247wallst.comInsider Buying of These 6 Stocks Surges: Fracking, Boats, a Buyout CandidateMay 25, 2024 | americanbankingnews.comThomas A. Mccarthy Purchases 10,000 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) StockMay 25, 2024 | americanbankingnews.comAdam Boehler Purchases 277,565 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) StockMay 25, 2024 | americanbankingnews.comPrivia Health Group (NASDAQ:PRVA) Shares Gap Up After Insider Buying ActivityMay 24, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Shares Gap Up on Insider Buying ActivityPrivia Health Group (NASDAQ:PRVA) Shares Gap Up After Insider Buying ActivityMay 24, 2024 | insidertrades.comPrivia Health Group, Inc. (NASDAQ:PRVA) Director Acquires $163,700.00 in StockMay 23, 2024 | finance.yahoo.comDirector Thomas McCarthy Acquires 10,000 Shares of Privia Health Group Inc (PRVA)May 21, 2024 | seekingalpha.comPrivia Health: Key Lessons Learned (Rating Downgrade)May 20, 2024 | marketbeat.comBarclays Lowers Privia Health Group (NASDAQ:PRVA) Price Target to $19.00Barclays cut their price objective on shares of Privia Health Group from $22.00 to $19.00 and set an "equal weight" rating for the company in a research report on Monday.May 20, 2024 | markets.businessinsider.comPrivia Health Group (PRVA) Gets a Hold from BarclaysMay 17, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Hits New 12-Month Low at $16.81Privia Health Group (NASDAQ:PRVA) Reaches New 1-Year Low at $16.81May 15, 2024 | markets.businessinsider.comWhat 12 Analyst Ratings Have To Say About Privia Health GrMay 15, 2024 | marketbeat.comTruist Financial Trims Privia Health Group (NASDAQ:PRVA) Target Price to $24.00Truist Financial dropped their target price on shares of Privia Health Group from $28.00 to $24.00 and set a "buy" rating for the company in a report on Wednesday.May 14, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), IN8bio (INAB) and Privia Health Group (PRVA)May 14, 2024 | insidertrades.comPrivia Health Group, Inc. (NASDAQ:PRVA) EVP Thomas Bartrum Sells 1,506 SharesMay 13, 2024 | marketbeat.comThomas Bartrum Sells 1,506 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) StockPrivia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) EVP Thomas Bartrum sold 1,506 shares of the business's stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $17.88, for a total transaction of $26,927.28. Following the completion of the transaction, the executive vice president now owns 102,356 shares in the company, valued at approximately $1,830,125.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.May 13, 2024 | finance.yahoo.comPrivia Health Group, Inc. (NASDAQ:PRVA) Q1 2024 Earnings Call TranscriptMay 10, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Price Target Cut to $26.00 by Analysts at Canaccord Genuity GroupCanaccord Genuity Group lowered their price target on Privia Health Group from $37.00 to $26.00 and set a "buy" rating on the stock in a research report on Friday.May 10, 2024 | finance.yahoo.comPrivia Health Group Inc (PRVA) Q1 2024 Earnings: Mixed Results Amid Operational GrowthMay 10, 2024 | finance.yahoo.comPrivia Health Group First Quarter 2024 Earnings: EPS: US$0.025 (vs US$0.064 in 1Q 2023)May 9, 2024 | finanznachrichten.dePrivia Health Group, Inc.: Privia Health Reports First Quarter 2024 Financial ResultsMay 9, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for Privia Health Group Amid Strong Financial Performance and Positive Growth OutlookMay 9, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Sets New 12-Month Low at $16.90Privia Health Group (NASDAQ:PRVA) Sets New 52-Week Low at $16.90May 9, 2024 | markets.businessinsider.comPrivia Health Q1 Net Profit More Than Halves; Backs FY24 Revenue OutlookMay 9, 2024 | msn.comPrivia Health Group Non-GAAP EPS of $0.18 beats by $0.03, revenue of $415.2M beats by $20.45MMay 9, 2024 | seekingalpha.comPrivia Health Group, Inc. 2024 Q1 - Results - Earnings Call PresentationMay 9, 2024 | globenewswire.comPrivia Health Reports First Quarter 2024 Financial ResultsMay 3, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on Privia Health Group (PRVA)May 3, 2024 | insidertrades.comInsider Selling: Privia Health Group, Inc. (NASDAQ:PRVA) EVP Sells 2,252 Shares of StockMay 3, 2024 | marketbeat.comFederated Hermes Inc. Cuts Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)Federated Hermes Inc. reduced its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 91.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,403 shares of the compaMay 2, 2024 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) EVP Sells $41,481.84 in StockPrivia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) EVP Thomas Bartrum sold 2,252 shares of the company's stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total transaction of $41,481.84. Following the completion of the transaction, the executive vice president now owns 103,862 shares in the company, valued at $1,913,138.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.May 1, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Price Target Lowered to $24.00 at Stifel NicolausStifel Nicolaus decreased their target price on Privia Health Group from $28.00 to $24.00 and set a "buy" rating for the company in a research report on Wednesday.April 23, 2024 | marketbeat.com51,400 Shares in Privia Health Group, Inc. (NASDAQ:PRVA) Acquired by Louisiana State Employees Retirement SystemLouisiana State Employees Retirement System purchased a new stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 51,400 sApril 22, 2024 | msn.comCitigroup Initiates Coverage of Privia Health Group (PRVA) with Buy RecommendationApril 22, 2024 | markets.businessinsider.comWhere Privia Health Gr Stands With AnalystsApril 22, 2024 | marketbeat.comPrivia Health Group (NASDAQ:PRVA) Earns Buy Rating from Analysts at CitigroupCitigroup assumed coverage on Privia Health Group in a research report on Monday. They issued a "buy" rating and a $25.00 price target for the company.April 21, 2024 | marketbeat.comPrivia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Kornitzer Capital Management Inc. KSKornitzer Capital Management Inc. KS trimmed its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 41.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 218,025 shares of the company's stock afApril 17, 2024 | marketbeat.comMirae Asset Global Investments Co. Ltd. Sells 56,744 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)Mirae Asset Global Investments Co. Ltd. reduced its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 25.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16April 11, 2024 | marketbeat.comPeregrine Capital Management LLC Has $5.14 Million Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA)Peregrine Capital Management LLC lessened its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 23.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 223,239 shares of the company's stock after sell Get Privia Health Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter. Email Address “This will be one of the biggest revolutions ever.” - NVIDIA CEO (Ad)NVIDIA's CEO calls it the "next amazing revolution"... The Economist says its a "boon to humanity"... And Jeff Bezos is heavily invested in it. A new breakthrough tech could add up to $20 trillion to the U.S. economy. PRVA Media Mentions By Week PRVA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRVA News Sentiment▼0.930.78▲Average Medical News Sentiment PRVA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRVA Articles This Week▼163▲PRVA Articles Average Week Get Privia Health Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: USPH News Today AGL News Today AMEH News Today ALHC News Today PHR News Today LFST News Today PNTG News Today INNV News Today CYRX News Today WGS News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRVA) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
